FIRST LEASE AMENDMENT

 Exhibit 10.34

FIRST LEASE AMENDMENT

This Lease Amendment made this 29^th day of October, 2019 by and between DUKE & DUKE, a Limited Partnership, of 00000 Xxxxx Xxxxx Xxxxxx, Xxxxx 000, Xxxxxxxxxx Xxxxx, XX 00000, as “LANDLORD” and Ocuphire Pharma, Inc. of 00000 Xxxxx Xxxxx Xxxxxx, Xxxxx 000, Xxxxxxxxxx Xxxxx, XX 00000, as “TENANT”.

WITNESSETH

WHEREAS, on or about the 19^th day of May, 2019, Landlord and Tenant entered into a Lease Agreement. The Lease together with any and all Amendments and/or riders is herein collectively referred to as, “Lease”. The certain demised premises consists of 1,623 rentable square feet and being commonly known as Suite 120 at 00000 Xxxxx Xxxxx Xxxxxx, Xxxxxxxxxx Xxxxx, XX 00000; and

WHEREAS, the parties wish to amend this Lease in respect to the demised premises in that Tenant wil1 extend the term of the original Lease Agreement; and

NOW THEREFORE, in consideration of monies to be paid and covenants and conditions to be performed, IT IS HEREBY AGREED AS FOLLOWS:

1. That the rent for the Suite known as Suite 120 will be as follows;

01/01/2020 — 12/31/2020            $22.00 per rentable square foot

2. That the expiration date of Tenant’s Lease shall be December 31, 2020.

3. Tenant Share: 2.l3%

4. Base Tax:        $1.39

5.           Miscellaneous: The Lease remains in full force and effect and has not been modified or extended except as specifically set in this First Amendment and extension of lease agreement. To the extent of any conflict between this Amendment and extension of lease agreement and the lease, the provisions of this First Amendment shall control.

TENANT:		LANDLORD:
Ocuphire Pharma, Inc.		DUKE & DUKE
		a Limited Partnership
/s/ Xxxx Xxxxx		/s/ Xxxxxx X. Xxxx, Xx.
Name: Xxxx Xxxxx		Xxxxxx X. Xxxx, Xx.
Its: CEO		Partner
Dated: 11/6/19		Dated: 11/6/2019